Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-52
Closed -$2.13K 57
2023
Q1
$2.13K Buy
52
+4
+8% +$167 ﹤0.01% 889
2022
Q4
$1.67K Buy
48
+4
+9% +$140 ﹤0.01% 963
2022
Q3
$1K Buy
44
+12
+38% +$389 ﹤0.01% 976
2022
Q2
$1K Buy
32
+18
+129% +$605 ﹤0.01% 955
2022
Q1
$1K Hold
14
﹤0.01% 538
2021
Q4
$1K Buy
+14
New +$628 ﹤0.01% 494

Other funds holding ADNT

Schubert & Co's ADNT Position: Q2 2023 in Review

Schubert & Co sold out of Adient (ADNT) in Q2 2023, closing a stake of 52 shares — an estimated $2.13K sold.

Schubert & Co first reported a position in ADNT in Q4 2021 and held it in 6 quarters. The position peaked at $2.13K in Q1 2023. 265 funds tracked by Wall St. Rank hold ADNT as of Q2 2023.

  • Schubert & Co reported no remaining Adient position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 52 Adient shares in Q2 2023, an estimated $2.13K.
  • Schubert & Co first reported a position in Adient in Q4 2021 and held it in 6 quarters.
  • Schubert & Co's Adient position peaked at $2.13K in Q1 2023.
  • 265 funds tracked by Wall St. Rank held Adient as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.